FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel Formulations of Palmitoylethanolamide, Presents Preclinical Toxicology Results at an International Symposium
Stock Information for FSD Pharma Inc.
Loading
Please wait while we load your information from QuoteMedia.